Sphere Medical

www.spheremedical.com

Sphere Medical Limited develops monitoring products to provide clinical and economic benefits in the critical care environment.

The products, all of which are based on the company’s proprietary technology, allow minimally invasive, real time measurement of clinical chemistry parameters and therapeutic drug concentrations, giving healthcare professionals the information they require to more effectively manage therapy and optimise patient outcomes.

Sphere Medical is a private company, founded in 2002 as a spin out from The Generics Group.

Staff

Dr Stuart Hendry, Chief Executive Officer and Director

Dr Hendry has 20 years experience in the medical device industry, having held positions at Pfizer Hospital Products, Diametrics Inc, PowderJect plc and the Generics Group. He has been involved in the commercialisation of numerous medical devices, many in the area of clinical monitoring and diagnostics
Dr Peter Laitenberger, VP Research and Development

Dr Laitenberger is responsible for Sphere’s research and product development activities. He has extensive experience in micro- and nanotechnology. Prior to joining Sphere, he held positions at the University of Birmingham, Scientific Generics and Oxford Instruments.
Dr Gavin Troughton, VP Business Development

Dr Troughton has over 15 years experience in the development and commercial exploitation of chemical sensors and related technologies. He worked for a number of years at Zellweger Analytics and at Scientific Generics, where he worked in their Business Innovation practice.

Contact details

Harston Mill
Harston
Cambridge
CB2 5GG

Tel: +44 (0)1223 875222
Fax: +44 (0)1223 875284
Articles relating to Sphere Medical

Sphere Medical raises £6.2m to progress chip-based medical sensors
Sagentia Group 1H revenues down 17%; pre-tax loss reaches £3m: sees ‘encouraging’ 2H
Generics Group boosted by public sector work; returns to the black, order book 'strong'
Generics losses grow as it boosts consulting revenue; hires advisers to update 'positioning'
Briefs: Meldex CEO leaves “with immediate effect”; Sphere Medical raises £5m
Subscribe

 

Corporate profiles

 • Zyentia


Chris Dobson
Founder and Scientific Advisor


Zyentia Limited is operating in the fields of protein misfolding and human disease. It was was formed in April 2002 and is based upon proprietary technologies relating to the prediction and measurement of peptide and protein folding, conformation and aggregation. The Company's principal IP arose

[Zyentia's profile]


Top20 Index




Currently: 71.78

Social Business Networking
Executives can now join in a social and business networking group. Check out the benefits.

Create Publisher Site
This Publisher Website ( slot3.siliconfenbusiness.com ) does not exist in Direct-Link-Ads.com. Please create it now.